President's Committee for People With Intellectual Disabilities (PCPID); Notice of Meeting, 51986 [2011-21240]
Download as PDF
<![CDATA[
51986
Federal Register / Vol. 76, No. 161 / Friday, August 19, 2011 / Notices
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: August 10, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
President’s Committee for People With
Intellectual Disabilities (PCPID); Notice
of Meeting
President’s Committee for
People with Intellectual Disabilities
(PCPID), Administration for Children
and Families, HHS.
ACTION: Notice of meeting.
AGENCY:
Monday, September 26, 2011,
from 8:30 a.m. to 5 p.m. EST; and
Tuesday, September 27, 2011, from 9
a.m. to 5 p.m. EST. The meeting will be
open to the public.
ADDRESSES: The meeting will be held in
Conference Room 505–A of the Hubert
H. Humphrey Building, U.S.
Department of Health and Human
Services, 200 Independence Avenue,
SW., Washington, DC 20201.
Individuals who would like to
participate via conference call may do
so by dialing 800–857–4846, pass code:
14201. Individuals who will need
accommodations for a disability in order
to attend the meeting (e.g., sign language
interpreting services, assistive listening
devices, materials in alternative format
such as large print or Braille) should
notify Genevieve Swift, PCPID
Executive Administrative Assistant, via
e-mail at Edith.Swift@acf.hhs.gov, or via
telephone at 202–619–0634, no later
than Monday, September 19, 2011.
PCPID will attempt to meet requests for
accommodations made after that date,
but cannot guarantee ability to grant
requests received after this deadline. All
meeting sites are barrier free.
Agenda: Committee members will
discuss preparation of the PCPID 2011
Report to the President, including its
content and format, and related data
collection and analysis required to
complete the writing of the Report.
jlentini on DSK4TPTVN1PROD with NOTICES
VerDate Mar<15>2010
18:32 Aug 18, 2011
Jkt 223001
PCPID
acts in an advisory capacity to the
President and the Secretary of Health
and Human Services, through the
Administration on Developmental
Disabilities, on a broad range of topics
relating to programs, services and
supports for persons with intellectual
disabilities. The PCPID Executive Order
stipulates that the Committee shall: (1)
Provide such advice concerning
intellectual disabilities as the President
or the Secretary of Health and Human
Services may request; and (2) provide
advice to the President concerning the
following for people with intellectual
disabilities: (A) Expansion of
educational opportunities; (B)
promotion of homeownership; (C)
assurance of workplace integration; (D)
improvement of transportation options;
(E) expansion of full access to
community living; and (F) increasing
access to assistive and universally
designed technologies.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2011–21167 Filed 8–18–11; 8:45 am]
DATES:
Additional Information: For further
information, please contact Laverdia
Taylor Roach, Senior Advisor,
President’s Committee for People with
Intellectual Disabilities, The Aerospace
Center, Second Floor West, 370 L’Enfant
Promenade, SW., Washington, DC
20447. Telephone: 202–619–0634. Fax:
202–205–9519. E-mail:
LRoach@acf.hhs.gov.
Dated: August 12, 2011.
Jamie Kendall,
Deputy Commissioner, Administration on
Developmental Disabilities.
[FR Doc. 2011–21240 Filed 8–18–11; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0410]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Premarket
Notification for a New Dietary
Ingredient
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(the PRA).
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Fax written comments on the
collection of information by September
19, 2011.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0330. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–3793.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
DATES:
Premarket Notification for a New
Dietary Ingredient—21 CFR 190.6—
(OMB Control Number 0910–0330)—
Extension
Section 413(a) of the Federal Food,
Drug, and Cosmetic Act (the FD&C Act)
(21 U.S.C. 350b(a)) provides that at least
75 days before the introduction or
delivery for introduction into interstate
commerce of a dietary supplement that
contains a new dietary ingredient (NDI),
a manufacturer or distributor of an NDI,
or of the dietary supplement that
contains the NDI, is to submit to FDA
(as delegate for the Secretary of Health
and Human Services) the information
which is the basis on which the
manufacturer or distributor has
concluded that a dietary supplement
containing an NDI will reasonably be
expected to be safe. Section 190.6 (21
CFR 190.6) implements this statutory
provision. Section 190.6(a) requires
each manufacturer or distributor of a
dietary supplement containing an NDI,
or of an NDI, to submit to the Office of
Nutrition, Labeling, and Dietary
Supplements notification of the basis for
their conclusion that said supplement or
ingredient will reasonably be expected
to be safe. Section 190.6(b) requires that
the notification include the following:
(1) The complete name and address of
the manufacturer or distributor, (2) the
name of the NDI, (3) a description of the
dietary supplements that contain the
NDI, and (4) the history of use or other
evidence of safety establishing that the
dietary ingredient will reasonably be
expected to be safe.
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 76, Number 161 (Friday, August 19, 2011)]
[Notices]
[Page 51986]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21240]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
President's Committee for People With Intellectual Disabilities
(PCPID); Notice of Meeting
AGENCY: President's Committee for People with Intellectual Disabilities
(PCPID), Administration for Children and Families, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
DATES: Monday, September 26, 2011, from 8:30 a.m. to 5 p.m. EST; and
Tuesday, September 27, 2011, from 9 a.m. to 5 p.m. EST. The meeting
will be open to the public.
ADDRESSES: The meeting will be held in Conference Room 505-A of the
Hubert H. Humphrey Building, U.S. Department of Health and Human
Services, 200 Independence Avenue, SW., Washington, DC 20201.
Individuals who would like to participate via conference call may do so
by dialing 800-857-4846, pass code: 14201. Individuals who will need
accommodations for a disability in order to attend the meeting (e.g.,
sign language interpreting services, assistive listening devices,
materials in alternative format such as large print or Braille) should
notify Genevieve Swift, PCPID Executive Administrative Assistant, via
e-mail at Edith.Swift@acf.hhs.gov, or via telephone at 202-619-0634, no
later than Monday, September 19, 2011. PCPID will attempt to meet
requests for accommodations made after that date, but cannot guarantee
ability to grant requests received after this deadline. All meeting
sites are barrier free.
Agenda: Committee members will discuss preparation of the PCPID
2011 Report to the President, including its content and format, and
related data collection and analysis required to complete the writing
of the Report.
Additional Information: For further information, please contact
Laverdia Taylor Roach, Senior Advisor, President's Committee for People
with Intellectual Disabilities, The Aerospace Center, Second Floor
West, 370 L'Enfant Promenade, SW., Washington, DC 20447. Telephone:
202-619-0634. Fax: 202-205-9519. E-mail: LRoach@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: PCPID acts in an advisory capacity to the
President and the Secretary of Health and Human Services, through the
Administration on Developmental Disabilities, on a broad range of
topics relating to programs, services and supports for persons with
intellectual disabilities. The PCPID Executive Order stipulates that
the Committee shall: (1) Provide such advice concerning intellectual
disabilities as the President or the Secretary of Health and Human
Services may request; and (2) provide advice to the President
concerning the following for people with intellectual disabilities: (A)
Expansion of educational opportunities; (B) promotion of homeownership;
(C) assurance of workplace integration; (D) improvement of
transportation options; (E) expansion of full access to community
living; and (F) increasing access to assistive and universally designed
technologies.
Dated: August 12, 2011.
Jamie Kendall,
Deputy Commissioner, Administration on Developmental Disabilities.
[FR Doc. 2011-21240 Filed 8-18-11; 8:45 am]
BILLING CODE 4184-01-P
